Product Benefits

Formet-V 50/500 mg Tablet is a combination of two active ingredients, Vildagliptin (a DPP-4 inhibitor) and Metformin (a biguanide), providing enhanced control over blood sugar levels.

• Dual-Action Glycemic Control: Combines two distinct mechanisms to achieve comprehensive blood sugar regulation, often effective when single-drug therapy is insufficient.

• Enhanced Insulin Function: Vildagliptin works by inhibiting the DPP-4 enzyme, which increases the levels of natural hormones (incretins) that stimulate the pancreas to produce more insulin when blood glucose is high, and simultaneously reduces glucagon production.

• Improved Insulin Sensitivity: Metformin works primarily by improving the body's sensitivity to insulin, helping muscles and other tissues absorb and utilize glucose more effectively.

• Reduced Liver Glucose Production: Metformin significantly decreases the amount of glucose produced and released by the liver (hepatic glucose production), lowering fasting blood sugar.

• Low Hypoglycemia Risk: Compared to some other diabetes medications (like sulfonylureas), the combination is generally associated with a lower risk of causing low blood sugar (hypoglycemia) when used alone.

• Convenience: A fixed-dose combination simplifies the treatment regimen by combining two medications into one tablet, improving patient adherence.